ERABALYZ Trademark

Trademark Overview

On Friday, January 14, 2022, a trademark application was filed for ERABALYZ with the United States Patent and Trademark Office. The USPTO has given the ERABALYZ trademark a serial number of 97219613. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Genentech, Inc.. The ERABALYZ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in oncology
erabalyz

General Information

Serial Number97219613
Word MarkERABALYZ
Filing DateFriday, January 14, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, January 18, 2022NEW APPLICATION ENTERED
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 24, 2022ASSIGNED TO EXAMINER
Monday, October 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 7, 2023SOU EXTENSION 1 FILED
Friday, July 7, 2023SOU EXTENSION 1 GRANTED
Monday, January 8, 2024SOU EXTENSION 2 GRANTED
Monday, January 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2024SOU EXTENSION 2 FILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 3 FILED
Tuesday, July 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, January 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

erabalyz oncology preparations pharmaceutical